{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:43:52Z","timestamp":1782873832419,"version":"3.54.5"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04952-8","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:16:34Z","timestamp":1777454194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A near-miss: case of pseudo-foreign body in End Stage Renal Disease"],"prefix":"10.1186","volume":"27","author":[{"given":"Hui Chuen","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Jun Han","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"4","key":"4952_CR1","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jsps.2015.01.009","volume":"24","author":"AM Shaman","year":"2016","unstructured":"Shaman AM, Kowalski SR. Hyperphosphatemia Management in Patients with Chronic Kidney Disease. Saudi Pharm J. 2016;24(4):494\u2013505. https:\/\/doi.org\/10.1016\/j.jsps.2015.01.009. Epub 2015 Jan 12. PMID: 27330380; PMCID: PMC4908098.","journal-title":"Saudi Pharm J"},{"key":"4952_CR2","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1681\/ASN.2004040275","volume":"16","author":"Y Slinin","year":"2005","unstructured":"Slinin Y, Foley RN, Collins AJ. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol. 2005;16:1788\u201393.","journal-title":"J Am Soc Nephrol"},{"key":"4952_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/sj.ki.5001542","volume":"70","author":"ML Melamed","year":"2006","unstructured":"Melamed ML, Eustace JA, Plantinga L, et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int. 2006;70:351\u20137.","journal-title":"Kidney Int"},{"key":"4952_CR4","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1177\/0091270006289846","volume":"46","author":"M Pennick","year":"2006","unstructured":"Pennick M, Dennis K, Damment SJ. Absolute bioavailability and disposition of lanthanum in healthy human subjects administered lanthanum carbonate. J Clin Pharmacol. 2006;46:738\u201346. [DOI] [PubMed] [Google Scholar].","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"4952_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.nephro.2007.11.005","volume":"4","author":"L Vrigneaud","year":"2008","unstructured":"Vrigneaud L, Lef\u00e8bvre D, Daem AO, Lemaitre V. Radiographic characteristics of lanthanum carbonate absorption. Nephrol Ther. 2008;4(2):111\u20133.","journal-title":"Nephrol Ther"},{"issue":"4","key":"4952_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s11604-010-0426-0","volume":"28","author":"H Hayashi","year":"2010","unstructured":"Hayashi H, Machida M, Sekine T, Yamaguchi H, Kiriyama T, Kumita S. Beam-hardening artifacts on computed tomography images caused by lanthanum carbonate hydrate in a patient on dialysis. JpnJ Radiol. 2010;28(4):322\u20134.","journal-title":"JpnJ Radiol"},{"key":"4952_CR7","unstructured":"Highlights of prescribing information. FOSRENOL (lanthanum carbonate) chewable tablets, for oral use. US Food and Drug Administration. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/021468s020,204734s001lbl.pdf (Accessed 8 June 2016)."},{"key":"4952_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1053\/j.ajkd.2014.01.424","volume":"63","author":"N Kurita","year":"2014","unstructured":"Kurita N, Uchihara H. Fecalith formation and colonic perforation after lanthanum carbonate granules administration. Am J Kidney Dis. 2014;63:861\u20132. [DOI] [PubMed] [Google Scholar].","journal-title":"Am J Kidney Dis"},{"key":"4952_CR9","first-page":"34","volume":"1421","author":"A Korzets","year":"2012","unstructured":"Korzets A. Lanthanum carbonate\/oxycodone constipation, peritonitis and perforated colonic diverticulum in an elderly patient: case report. React Wkly. 2012;1421:34. [Google Scholar].","journal-title":"React Wkly"},{"key":"4952_CR10","doi-asserted-by":"crossref","unstructured":"Girish Namagondlu, Main N, Yates L, Mooney J, Sangita Sathyamurthy, Daryanani I, et al. Lanthanum associated abnormal liver function tests in two patients on dialysis: a case report. J Med Case Rep. 2009;3(1).","DOI":"10.1186\/1752-1947-3-9321"},{"key":"4952_CR11","doi-asserted-by":"crossref","unstructured":"Birk M, Bauerfeind P, Deprez P, H\u00e4fner M, Hartmann D, Hassan C, et al. Removal of foreign bodies in the upper gastrointestinal tract in adults: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy [Internet]. 2016;48(05):489\u201396. Available from: https:\/\/www.esge.com\/assets\/downloads\/pdfs\/guidelines\/2016_s_0042_100456.pdf","DOI":"10.1055\/s-0042-100456"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04952-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04952-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04952-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:50:03Z","timestamp":1782870603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04952-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4952"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04952-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient has provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of patient\u2019s clinical details and\/or clinical images was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"397"}}